NCT05386290 A Multicentered Prospective Cohort Study of Chinese IBD Patients Status UNKNOWN Phase N/A
NCT05299931 An Open-Label Extension and Long-term Efficacy and Safety Monitoring Study of Patients with Crohn's Disease Previously Included in the Loss of RESponse to Ustekinumab Treated by Dose Escalation Study Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05270733 Development of Predictive Psoriasis Response Endotypes Using Single Cell Transcriptomics Status RECRUITING Phase PHASE4
NCT05252533 A Study of Ustekinumab in Pediatric Participants (U-POPS) With Juvenile Psoriatic Arthritis or Psoriasis Status COMPLETED Phase PHASE1
NCT05242458 A Study of Ustekinumab Treatment in Children With Crohn's Disease Status COMPLETED Phase N/A
NCT05092269 A Long-term Extension Study of Ustekinumab in Pediatric Participants Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05083182 A Study of Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis Status COMPLETED Phase PHASE3
NCT05029921 A Study of Ustekinumab (STELARA) in Chinese Participants With Moderately to Severely Active Crohn's Disease Status COMPLETED Phase PHASE4
NCT04978493 A Study to Test Whether BI 706321 Combined With Ustekinumab Helps People With Crohn's Disease Status TERMINATED Phase PHASE2
NCT04963725 A Study of Symptom Improvement of Ulcerative Colitis After an Induction Dose of Ustekinumab in Japanese Clinical Practice Status COMPLETED Phase N/A
NCT04882072 A Study of Ustekinumab in Participants With Takayasu Arteritis (TAK) Status TERMINATED Phase PHASE3
NCT04816513 A Study to Assess the Bioequivalence of Ustekinumab by Two Different Injection Devices in Healthy Participants Status COMPLETED Phase PHASE1
NCT04772274 A Study to Compare SB17 (Proposed Ustekinumab Biosimilar) to European Union (EU) Sourced Stelara and United States of America (US) Sourced Stelara in Healthy Subjects Status COMPLETED Phase PHASE1
NCT04761627 A Study to Investigate Interchangeability of ABP 654 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT04673357 A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease Status COMPLETED Phase PHASE3
NCT04655807 A Study of JNJ-64304500 as Add-on Therapy in Participants With Active Crohn's Disease Status WITHDRAWN Phase PHASE2
NCT04632927 Efficacy of Secukinumab Compared to Ustekinumab in Adults With Active Psoriatic Arthritis and Failure of TNFα-Inhibitor Treatment Status COMPLETED Phase PHASE3
NCT04610476 Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic Arthritis Status UNKNOWN Phase PHASE3
NCT04607980 A Study to Investigate ABP 654 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis Status COMPLETED Phase PHASE3